AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Auvinen, A Vornanen, T Tammela, TLJ Ala-Opas, M Leppilahti, M Salminen, P Hakama, M
Citation: A. Auvinen et al., A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics, BJU INT, 88(7), 2001, pp. 708-715

Authors: Sudah, M Vanninen, R Partanen, K Heino, A Vainio, P Ala-Opas, M
Citation: M. Sudah et al., MR urography in evaluation of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography, AM J ROENTG, 176(1), 2001, pp. 105-112

Authors: Aaltomaa, S Lipponen, P Ala-Opas, M Kosma, VM
Citation: S. Aaltomaa et al., Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer, EUR UROL, 39(2), 2001, pp. 138-144

Authors: Gronlund-Pakkanen, S Pakkanen, TM Koski, E Talja, M Ala-Opas, M Alhava, E
Citation: S. Gronlund-pakkanen et al., Effect of photodynamic therapy on urinary bladder function: an experimental study with rats, UROL RES, 29(3), 2001, pp. 205-209

Authors: Tuhkanen, K Heino, A Ala-Opas, M
Citation: K. Tuhkanen et al., Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates, SC J UROL N, 35(3), 2001, pp. 200-204

Authors: Aaltomaa, S Ala-Opas, M
Citation: S. Aaltomaa et M. Ala-opas, The effect of transurethral needle ablation on symptoms of chronic pelvic pain syndrome - A pilot study, SC J UROL N, 35(2), 2001, pp. 127-131

Authors: Raitanen, MP Marttila, T Nurmi, M Ala-Opas, M Nieminen, P Aine, R Tammela, TLJ Group, F
Citation: Mp. Raitanen et al., Human complement factor H related protein test for monitoring bladder cancer, J UROL, 165(2), 2001, pp. 374-377

Authors: Gronlund-Pakkanen, S Pakkanen, TM Talja, M Kosma, VM Ala-Opas, M Alhava, E
Citation: S. Gronlund-pakkanen et al., The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX, BJU INT, 86(1), 2000, pp. 126-132

Authors: Aaltomaa, S Lipponen, P Viitanen, J Kankkunen, JP Ala-Opas, M Kosma, VM
Citation: S. Aaltomaa et al., Prognostic value of CD44 standard, variant isoforms 3 and 6 and alpha-catenin expression in local prostate cancer treated by radical prostatectomy, EUR UROL, 38(5), 2000, pp. 555-562

Authors: Lipponen, P Aaltomaa, S Kellokoski, J Ala-Opas, M Kosma, VM
Citation: P. Lipponen et al., Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation, EUR UROL, 37(5), 2000, pp. 573-578

Authors: Liukkonen, T Lipponen, P Raitanen, M Kaasinen, E Ala-Opas, M Rajala, P Kosma, VM
Citation: T. Liukkonen et al., Evaluation of p21(WAF1/CIP1) and cyclin D-1 expression in the progression of superficial bladder cancer, UROL RES, 28(5), 2000, pp. 285-292

Authors: Lumiaho, J Heino, A Pietilainen, T Ala-Opas, M Talja, M Valimaa, T Tormala, P
Citation: J. Lumiaho et al., The morphological, in situ effects of a self-reinforced bioabsorbable polylactide (SR-PLA 96) ureteric stent; An experimental study, J UROL, 164(4), 2000, pp. 1360-1363

Authors: Lumiaho, J Heino, A Tunninen, V Ala-Opas, M Talja, M Valimaa, T Tormala, P
Citation: J. Lumiaho et al., New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: An experimental study, J ENDOUROL, 13(2), 1999, pp. 107-112

Authors: Heino, A Aaltomaa, S Ala-Opas, M
Citation: A. Heino et al., BTA test is superior to voided urine cytology in detecting malignant bladder tumours, ANN CHIR GY, 88(4), 1999, pp. 304-307

Authors: Aaltomaa, S Lipponen, P Eskelinen, M Ala-Opas, M Kosma, VM
Citation: S. Aaltomaa et al., Prognostic value and expression of p21(wafl/cip1) protein in prostate cancer, PROSTATE, 39(1), 1999, pp. 8-15

Authors: Tuhkanen, K Heino, A Ala-Opas, M
Citation: K. Tuhkanen et al., Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml - Six-month follow-up with complex urodynamic assessment, SC J UROL N, 33(1), 1999, pp. 31-34

Authors: Aaltomaa, S Lipponen, P Ala-Opas, M Eskelinen, M Kosma, VM
Citation: S. Aaltomaa et al., alpha-Catenin expression has prognostic value in local and locally advanced prostate cancer, BR J CANC, 80(3-4), 1999, pp. 477-482

Authors: Aaltomaa, S Lipponen, P Ala-Opas, M Eskelinen, M Syrjanen, K Kosma, VM
Citation: S. Aaltomaa et al., Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival, BR J CANC, 80(12), 1999, pp. 2001-2007
Risultati: 1-18 |